Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 23 12:05PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.25 Insider Own8.56% Shs Outstand293.35M Perf Week-65.92%
Market Cap1.72B Forward P/E- EPS next Y-4.20 Insider Trans0.00% Shs Float268.24M Perf Month-42.49%
Income-38.32M PEG- EPS next Q-1.20 Inst Own1.99% Short Float0.09% Perf Quarter62.84%
Sales10.14M P/S169.59 EPS this Y94.97% Inst Trans-2.70% Short Ratio0.20 Perf Half Y-71.88%
Book/sh0.04 P/B133.63 EPS next Y22.22% ROA-68.24% Short Interest0.24M Perf Year-86.89%
Cash/sh0.04 P/C147.36 EPS next 5Y40.00% ROE-351.06% 52W Range3.07 - 45.00 Perf YTD-35.47%
Dividend Est.- P/FCF- EPS past 5Y86.10% ROI-103.37% 52W High-86.97% Beta0.73
Dividend TTM- Quick Ratio1.39 Sales past 5Y39.38% Gross Margin58.02% 52W Low90.83% ATR (14)2.65
Dividend Ex-Date- Current Ratio1.89 EPS Y/Y TTM94.68% Oper. Margin-318.44% RSI (14)33.31 Volatility17.83% 19.45%
Employees49 Debt/Eq2.31 Sales Y/Y TTM-10.29% Profit Margin-377.95% Recom1.00 Target Price360.00
Option/ShortNo / Yes LT Debt/Eq1.56 EPS Q/Q97.57% Payout- Rel Volume1.37 Prev Close7.69
Sales Surprise-21.63% EPS Surprise-100.00% Sales Q/Q19.22% EarningsMay 14 BMO Avg Volume1.22M Price5.86
SMA20-60.10% SMA50-38.73% SMA200-56.99% Trades Volume710,654 Change-23.73%
Date Action Analyst Rating Change Price Target Change
Jul-07-21Initiated Cantor Fitzgerald Overweight $5
Jul-11-17Initiated Rodman & Renshaw Buy $2
Today 08:30AM
May-20-24 10:25AM
May-17-24 04:49PM
04:15PM Loading…
May-15-24 03:02AM
May-14-24 10:52AM
May-13-24 12:35PM
May-09-24 10:35AM
May-08-24 08:30AM
May-07-24 12:31PM
May-06-24 09:04AM
07:31AM Loading…
May-03-24 07:31AM
Apr-29-24 08:30AM
Apr-22-24 08:45AM
Apr-18-24 08:30AM
Apr-16-24 11:34AM
Apr-10-24 10:40AM
Apr-09-24 04:15PM
Apr-08-24 08:30AM
Apr-02-24 11:24AM
Apr-01-24 12:52PM
Mar-27-24 08:30AM
08:30AM Loading…
Mar-20-24 08:30AM
Feb-23-24 08:30AM
Feb-15-24 08:30AM
Feb-14-24 08:30AM
Feb-12-24 08:30AM
Jan-30-24 08:45AM
Jan-29-24 08:30AM
Jan-25-24 08:30AM
Jan-05-24 04:15PM
Jan-04-24 08:30AM
Dec-24-23 05:48PM
Dec-11-23 08:30AM
Dec-07-23 08:30AM
Dec-06-23 08:30AM
Dec-04-23 08:30AM
Nov-30-23 08:30AM
Nov-21-23 08:30AM
Nov-15-23 01:14PM
Nov-14-23 09:00PM
Nov-10-23 04:15PM
Nov-09-23 08:30AM
Nov-08-23 10:25AM
Nov-07-23 08:30AM
Nov-02-23 08:30AM
Nov-01-23 08:30AM
Oct-31-23 07:00AM
Oct-30-23 08:30AM
Oct-26-23 08:30AM
Oct-25-23 08:00AM
Oct-23-23 08:30AM
Oct-19-23 08:30AM
Oct-18-23 08:30AM
Oct-12-23 08:30AM
Oct-10-23 08:30AM
Sep-28-23 08:30AM
Sep-27-23 08:30AM
Sep-26-23 08:30AM
Sep-21-23 07:30AM
Sep-14-23 08:30AM
Sep-13-23 08:30AM
Sep-12-23 08:30AM
Sep-11-23 08:30AM
Sep-07-23 08:30AM
Sep-05-23 07:00AM
Aug-30-23 08:30AM
Aug-28-23 08:30AM
Aug-24-23 07:00AM
Aug-17-23 08:30AM
Aug-16-23 08:30AM
Aug-14-23 10:16PM
Aug-10-23 08:30AM
Aug-09-23 08:30AM
Aug-08-23 08:30AM
Aug-07-23 08:30AM
Aug-03-23 08:30AM
Aug-02-23 08:30AM
Aug-01-23 08:40AM
Jul-27-23 08:30AM
Jul-26-23 08:30AM
Jul-25-23 08:30AM
Jul-07-23 04:15PM
Jun-28-23 08:30AM
Jun-26-23 08:30AM
Jun-22-23 08:30AM
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.